VAXON Biotech researches and develops therapeutic vaccines for the treatment of lung, gastric, prostate, breast, liver and colorectal cancers. VAXON Biotech was founded in 2004. VAXON Biotech's headquarters is located in Paris, Île-de-France, FR 75749...
VAXON Biotech's CEO, Kostas Kosmatopoulos, currently has an approval
rating of 89%. VAXON Biotech's primary competitors are
There are no competitors identified for VAXON Biotech
There have been no acquisitions found related to VAXON Biotech
Recent investment data cannot be found related to VAXON Biotech